Ahmedabad, India

Sumitra Ashok Pillai

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Dr. Reddy's Laboratories, Incorporated, Avyxa Holdings, LLC. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumitra Ashok Pillai. Retrieved from https://idiyas.com/inventor/sumitra-ashok-pillai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sumitra Ashok Pillai: Innovator in Pharmaceutical Formulations

Introduction

Sumitra Ashok Pillai is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment. With a total of three patents to his name, his work has the potential to impact the medical community positively.

Latest Patents

One of his latest patents focuses on stable liquid formulations of cyclophosphamide. This invention comprises cyclophosphamide and at least one pharmaceutically acceptable excipient, with a moisture content of less than about 2.0% by weight. The process involves reducing the moisture content from cyclophosphamide or its liquid compositions. Furthermore, the stable liquid formulations are designed for parenteral administration, either as ready-to-use or ready-to-dilute options for treating various cancer disorders.

Career Highlights

Throughout his career, Sumitra has worked with reputable companies such as Dr. Reddy's Laboratories and Avyxa Holdings. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Riyaz Ahmed Shaik and Ananya Saha, who have collaborated with him on various projects.

Conclusion

Sumitra Ashok Pillai's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical treatments. His innovative work in stable liquid formulations of cyclophosphamide showcases the potential for improving cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…